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Abstract
This study in Burkina Faso investigated whether offspring of young mothers who had
received weekly periconceptional iron supplementation in a randomised controlled
trial were at increased risk of malaria. A child safety survey was undertaken in the
peak month of malaria transmission towards the end of the trial to assess child iron
biomarkers, nutritional status, anaemia and malaria outcomes. Antenatal iron bio-
markers, preterm birth, fetal growth restriction and placental pathology for malaria
and chorioamnionitis were assessed. Data were available for 180 babies surviving to
the time of the survey when their median age was 9 months. Prevalence of maternal
iron deficiency in the last trimester based on low body iron stores was 16%. Preva-
lence of active placental malaria infection was 24.8%, past infection 59% and
chorioamnionitis 55.6%. Babies of iron supplemented women had lower median ges-
tational age. Four out of five children ≥ 6 months were iron deficient, and 98% were
anaemic. At 4 months malaria prevalence was 45%. Child iron biomarkers, anaemia
and malaria outcomes did not differ by trial arm. Factors associated with childhood
parasitaemia were third trimester C-reactive protein level (OR 2.1; 95% CI 1.1–3.9),
active placental malaria (OR 5.8; 1.0–32.5, P = 0.042) and child body iron stores
(OR 1.13; 1.04–1.23, P = 0.002). Chorioamnionitis was associated with reduced risk
of child parasitaemia (OR 0.4; 0.1–1.0, P = 0.038). Periconceptional iron supplemen-
tation of young women did not alter body iron stores of their children. Higher child
body iron stores and placental malaria increased risk of childhood parasitaemia.
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1 | INTRODUCTION
Better iron status has been associated with increased Plasmodium
falciparum infection risk early in pregnancy (Diallo et al., 2020; Moya-
Alvarez et al., 2015) and iron deficiency at delivery with decreased
prevalence of placental malaria (Kabyemela, Fried, Kurtis,
Mutabingwa, & Duffy, 2008; Senga, Harper, Koshy, Kazembe, &
Brabin, 2011), suggesting a direct effect of maternal iron status on
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placental iron homeostasis. Placental adaptation, allowing optimal
transfer of iron from the maternal circulation to the fetus (Sangkhae
et al., 2020; Scholl, 2011), may be impaired by malaria. Malaria in
pregnancy is also reported as a predictor of infant haemoglobin
(Hb) levels (Accrombessi et al., 2015; Le Cessie et al., 2002).
Cohort studies from Benin (Moya-Alvarez et al., 2017), Malawi
(Jonker et al., 2012), Tanzania (Gwamaka et al., 2012), Zambia
(Barffour et al., 2017), Kenya and Uganda (Muriuki et al., 2019) have
reported that better iron status in young children predicted increased
future malaria risk, with iron deficiency significantly decreasing odds
of subsequent parasitaemia. A twofold increased risk in young children
of malaria parasitaemia and clinical malaria was also seen in mothers
experiencing P. falciparum infections during pregnancy (Park
et al., 2020), with several studies identifying an association of
increased child malaria with placental malaria in their mothers (Agbota,
Accrombessi, et al., 2019; Asante et al., 2013; Awine et al., 2016;
Bardají et al., 2011; Le Port et al., 2011; Schwarz et al., 2008; Sylvester
et al., 2018; Sylvester et al., 2016). Given the protective effect of iron
deficiency during pregnancy for malaria (Diallo et al., 2020;
Kabyemela, Fried, Kurtis, Mutabingwa, & Duffy, 2008; Moya-Alvarez
et al., 2015; Senga, Harper, Koshy, Kazembe, & Brabin, 2011), it fol-
lows that young children born to iron replete mothers, enhanced by
routine periconceptional or antenatal iron supplementation, could be
at higher risk of malaria, although the issue is complex as immunologi-
cal mechanisms (Brickley et al., 2015; Broen, Brustoski, Engelmann, &
Luty, 2007; Dechavanne et al., 2017; Feeney, 2020; Hviid, 2009; Hviid
& Staalsoe, 2004; Park et al., 2019; Sylvester et al., 2018) and maternal
factors such as breast feeding and use of antimalarial drugs are rele-
vant (Hawking, 1954; Kakuru, Staedke, Dorsey, Rogerson, & Chan-
dramohan, 2019; Natama, Rovira-Vallbona, Sorgho, et al., 2018).
To determine childhood malaria risk in relation to maternal and
offspring iron status a cohort of children born to mothers who partici-
pated in a randomised double blind controlled safety trial of per-
iconceptional weekly iron supplementation (Gies et al., 2018) was
assessed during the peak month of malaria transmission towards the
end of the trial. A child safety survey became necessary after publica-
tion in 2012 (post trial commencement) of two cohort studies that
reported iron repletion predicted increased malaria risk in pre-school
children in Malawi (Jonker et al., 2012) and Tanzania (Gwamaka
et al., 2012). The objectives of this cross-sectional child safety study
were firstly, in children under 2 years of age, to determine
prespecified malaria-related outcomes and anaemia and iron bio-
markers by trial arm, and secondly, to characterise maternal and child
iron status and related factors associated with child malaria.
2 | MATERIALS AND METHODS
Written, informed consents were given by all individuals, with addi-
tional guardian consents provided for minors. The work described was
carried out in accordance with the Code of Ethics of the World Medi-
cal Association (Declaration of Helsinki). The primary trial outcome
was malaria prevalence at the first antenatal visit, but women were
followed till delivery and gestational age, preterm birth, birthweight,
placental malaria and neonatal deaths have been reported (Gies
et al., 2018). The survey in children was introduced as a safety amend-
ment to the registered trial protocol with a prespecified secondary
outcome of malaria parasite prevalence. The main results of the study
were communicated to communities at the end of the study.
2.1 | Trial procedures
The main trial was undertaken between April 2011 and January 2014
in the rural area of Nanoro in Burkina Faso where malaria is hyper-
endemic with seasonal transmission. The study participants were
enrolled within the Nanoro Health and Demographic Surveillance
catchment area which had a population of approximately 55000
inhabitants. HIV prevalence in this population was 1.2% in women
aged 15–49 years and 0.76% among pregnant women (Institut
National de la Statistique et de la Démographie [INSD] et ICF
International, 2012). Background and published data on the trial,
randomisation and design (Brabin, Gies, et al., 2019; Diallo
et al., 2020; Gies et al., 2018) are summarised in Appendix S1.
2.2 | Pregnancy assessments
Nulliparous participants had been individually randomised to receive,
directly observed, either a weekly capsule containing ferrous gluco-
nate (60 mg) and folic acid (2.8 mg) (n = 980), or an identical capsule
containing folic acid alone (2.8 mg) (n = 979) for up to 18 months, or
till pregnancy occurred (Gies et al., 2018; Appendix S1). Iron status
was assessed at recruitment. For women who became pregnant, a
venepuncture sample was collected for measurement of iron status
and malaria infection at a study antenatal visit scheduled at around
13–16 weeks gestation (ANC1) and at a second scheduled study visit
between 33 and 36 weeks gestation (ANC2). At delivery the placenta
was analysed for malaria parasites. From ANC1 onwards women
received standard antenatal care including daily iron and folic acid
Key messages
• Iron deficiency prevalence in young mothers in Burkina
Faso was low.
• Periconceptional iron supplements did not alter placental
or child malaria risk.
• Malaria parasitaemia risk was higher in children with bet-
ter iron status.
• Placental malaria increased risk of child malaria.
• Intensified efforts are needed to reduce risk of placental
malaria which should, in turn, reduce risk of malaria and
anaemia in young children.
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supplements until delivery (60-mg iron, 400-μg folic acid daily). All
women received a first dose of intermittent preventive treatment with
sulphadoxine pyrimethamine (IPTp) at ANC1 if gestational age was
>13 weeks. Women ≤ 13 weeks gestation, if positive for malaria by
rapid diagnostic test (RDT) (Bioline SD, Malaria Antigen Pf detecting
P. falciparum histidine-rich protein 2), were treated with oral quinine. A
second scheduled IPTp-SP dose was provided through routine antena-
tal care. Gestational age was estimated by ultrasound examination at
ANC1 with a FF Sonic UF-4100 (Fukuda Denshi) scanner, with mea-
surement of crown rump length in the first trimester and by biparietal
diameter, femur length and abdominal circumference afterward.
2.3 | Newborn assessments
At delivery study nurses examined babies within 24–48 h of delivery,
and recorded birthweight, using an electronic scale to within 10 g
(SECA 384, Hamburg, Germany, precision ± 5 g for weights < 5000 g,
±10 g above 5000 g). Delayed umbilical cord clamping was routinely
practised. Following hospital delivery, placental biopsies (2.5 × 1 cm)
were excised from fetal and maternal sites at mid-distance between
umbilical cord insertion and the placental border and placed in 10%
neutral buffered formalin. Rural health centres were also trained and
equipped to take placenta samples. Placental biopsies were not avail-
able from home deliveries.
2.4 | Child assessments
In the wet season in October 2013, mothers who had delivered and
remained in the study area were invited to have their offspring
assessed at the Clinical Research Unit of Nanoro (CRUN) Health
Clinic. The follow-up child assessment was performed by experi-
enced paediatric nursing research staff and included: medical and
vaccination history (BCG and polio at birth; pentavalent diphtheria,
tetanus, pertussis, hepatitis B, Haemophilus influenzae type B and
polio at 2, 3 and 4 months; measles at 9 months; yellow fever at
12 months). Health cards were examined and reports of recent ill-
ness, fever and drug intake within the last 2 weeks were checked.
Anthropometric measurements were performed in duplicate by two
independent observers and mean values computed. Children were
weighed to the nearest 10 g with an electronic scale (SECA
384, Hamburg, Germany, precision ± 5 g for weights < 5000 g,
±10 g above 5000 g). Length was measured to the nearest 5 mm
using a measuring mat (SECA 210, Germany) and mid-upper arm cir-
cumference to the nearest mm using a circumference tape (SECA
201, Germany). Clinical examination was completed with tempera-
ture. A venepuncture blood sample was collected. The volume of
blood sampled differed by weight, 1 ml in EDTA and 4 ml in a dry
tube for infants ≥ 5600 g and 0.5 and 3.0 ml, respectively, for lower
weights. This was used for malaria microscopy and RDT for malaria,
Hb, serum iron biomarkers (ferritin, transferrin receptor and zinc
protoporphyrin), C-reactive protein (CRP) and a reserve filter paper
blood spot. Children diagnosed with malaria, or any other concur-
rent health problem, received free treatment according to National
Guidelines, with appropriate follow-up.
2.5 | Laboratory procedures
Blood samples were transported within 3 h from the clinic to the cen-
tral project laboratory at CRUN. Sera aliquots were stored at −80C.
Hb was measured (Sysmex automated analyser) and ZPP by fluorome-
try (Aviv Biomedical) on fresh whole blood. Anaemia in chil-
dren ≥ 6 months was defined as Hb < 11 g dl−1. Plasma ferritin and
TfR were measured using mean values from duplicate ELISA samples
(Spectro Ferritin S-22 and TFC 94 TfR, RAMCO Inc.) and CRP by
ELISA (EU59131IBL, GmbH). Intra-assay coefficients of variation
(CVs) were all <10%. Ranges for normal controls were ferritin, 69.1–
114.7 μg L−1; sTfR, 4.2–5.9 mg L−1; CRP, 5–8 mg L−1. Definitions of
iron status were based on (1) adjusted ferritin using the internal
regression correction approach (Namaste et al., 2017), allowing for
inflammation as described by Mei et al. (2017), or (2) the ratio of sTfR
(mg L−1) to log10 ferritin (μg L−1), which assesses both stored and
functional iron and is possibly less affected by inflammation.
Values > 5.6 in children derive from the cut-offs sTfR > 8.3 μg ml−1
and ferritin < 30 μg L−1. This best predicted iron deficient bone mar-
row stores using the same assay as in the present study, in an area of
high malaria transmission (Phiri et al., 2009). Body iron stores (BIS)
(mg kg−1) using the regression-adjusted ferritin estimate were calcu-
lated using the equation derived by Cook, Flowers, and Skikne (2003):
body iron (mg kg−1) = −[log10 (1000 × sTfR/ferritin) − 2.8229]/0.1207
[39]. Low BIS was defined as <0 mg kg−1. Plasma hepcidin was mea-
sured by competitive ELISA at an International Reference Laboratory
(Kroot et al., 2010). A malaria RDT was performed. Malaria parasite
density was obtained from the mean count of two independent
readers counting the number of asexual parasites per 200 white blood
cells in a thick blood film stained with 3% Giemsa, assuming a white
cell count of 8000/μl. For discrepant findings (positive/negative; more
than twofold difference for parasite densities ≥ 400/μl; >log10 if
<400/μl), a third independent reading was made, with the mean of the
two closest observations accepted as the true value.
2.6 | Placental histology
After the delivery of the placenta, it was placed in a receptacle fetal
side upwards. Using scissors, a biopsy of 2.5 cm × 1 cm was excised
at mid-distance between the insertion of the umbilical cord and the
placenta border and placed into a prefilled specimen container with
10% neutral buffered formalin (CellStor Pot, CellPath Ltd. Newtown
SY16 4LE, UK). A 1 cm cross-section from the umbilical cord was cut
with scissors at about 5 cm from the insertion and placed into the
same receptacle. After turning the placenta in order to expose the
maternal side upwards, a second biopsy of about the same size was
excised at half distance between the centre and the border of the
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placenta and placed into a second container with formalin. A
10 cm × 10 cm piece of the membrane was cut with scissors and
placed into the same container.
Formalin fixed specimens were stored for up to 3 months at room
temperature in an air-conditioned room (20C) at the CRUN labora-
tory. After transport to the department of pathology at the National
University Hospital Yalgado Ouedraogo in Ouagadougou, tissue sam-
ples were processed by experienced technicians according to standard
histopathological procedures.
Samples were embedded in paraffin wax following standard
methods. Membranes were rolled to cylinders in order to obtain suffi-
cient material to be cut and embedded. For each set of samples, paraf-
fin sections 3 to 5 μm thick were placed on two slides, the fetal side
of the placenta together with the cord on one slide, the maternal side
of the placenta together with the membrane on another slide. Slides
were prepared in duplicate to allow for different staining. De-
paraffinised sections were stained with haematoxylin and eosin and
Giemsa stain. Histological examination of all samples was done by a
specialised senior pathologist with light microscopy and under
polarised light. Histological classification of placental malaria was
based on the different significance of haemozoin and parasitised RBC
in the intervillous space of the maternal side of the placenta as
described by Ismail et al. (2000): acute infection (only parasites and
minimal haemozoin deposition in the macrophages but not fibrin),
chronic infection (parasites and haemozoin deposition), past infection
(haemozoin usually mixed with fibrin but no parasites) and no infec-
tion. Chorioamnionitis was graded histologically following the
Redline-classification (Redline, 2002).
2.7 | Statistical analysis
The sample size was determined from formal power calculations for
the malaria trial endpoints (Gies et al., 2018). The number of children
available for assessment per study arm is shown in Figure S1 (see
Appendix S2). The primary analyses presented here are comparisons
of prespecified child malaria-related outcomes and placental malaria
in babies by trial arm on an intention to treat basis. Iron and inflamma-
tion biomarkers and placental chorioamnionitis were prespecified
exploratory outcomes. Preterm was defined as a live birth or stillbirth
that took place at least 20 but before 37 completed weeks. Fetal
growth restriction (SGA) was defined as birthweight below the 10th
centile for gestation and gender, indicated by standard reference data
(Villar et al., 2014). Clinical malaria was defined as fever or history of
fever (≥37.5C) in the previous 48 h with parasitaemia. Outcomes
were summarised by median (interquartile range) or N (%) and com-
pared between treatment arms using ordinary or logistic regression
models adjusting for child sex and age at assessment. Age was fitted
with a cubic spline function with 5 degrees of freedom, with sensitiv-
ity analyses confirming that this was a sufficient representation of the
non-linear age relationships. Results are presented as odds ratios for
categorical outcomes or differences between arms for continuous var-
iables with 95% CI. Where appropriate, outcomes were log
transformed and the presented effect size can be interpreted as a ratio
between arms.
Malaria prevalence by age in various subgroups was visualised
using the fitted probabilities from a logistic regression model using a
cubic spline representation with the degrees of freedom selected to
capture the main features of the age trends without spurious artefacts.
Shading around the fitted lines to indicate ±1SE, and rugplots showing
the location of positive and negative values (tick marks along top and
bottom axes) were added where these did not obscure the
presentation.
The associations between infant/maternal factors and infant
malaria were assessed using logistic regression models for malaria out-
comes against the relevant factors, adjusting for age and sex as above.
The associations between iron biomarkers and malaria were visualised
as scatterplots of the relationship between the biomarker and age for
the children with and without malaria, with cubic spline regression
lines added for each group. All analyses were performed in the R sta-
tistical environment version 3.6.
2.8 | Ethical considerations
This child outcome analysis was conducted as a safety assessment of
malaria risk in the first born offspring of young mothers enrolled in a
randomised periconceptional trial of weekly iron and folic acid supple-
mentation (PALUFER). The study received ethical approvals in Burkina
Faso; National Ethics Committee (CERS Ref 015-2020/CE-CM) and
the Comité d'Ethique pour la Recherche en Santé du Centre Muraz
(015-2010/CE-CM); the United Kingdom Research Ethics Committee,
Liverpool School of Tropical Medicine (LSTM/REC protocol 10-55);
the Institutional Review Board of the Institute of Tropical Medicine
(IRB/AB/AC/016) and the Antwerp University Hospital Ethics Com-
mittee, Belgium (EC/UZA). The trial was registered with Clinicaltrials.
gov on 27 September 2010: https://clinicaltrials.gov/show/
NCT01210040.
3 | RESULTS
3.1 | Participants
During the trial 478 pregnancies occurred, with 348 known deliveries
occurring before the survey period (Figure S1 in Appendix S2). Follow-
ing exclusions due to out-migration, stillbirths and neonatal and infant
deaths, there were 262 babies eligible for this study. Of these,
180 (69% of those eligible) were contacted, assessed and included in
the primary analyses presented here.
3.2 | Maternal and child characteristics by trial arm
Maternal characteristics at delivery and offspring characteristics by
trial arm are shown in Table 1. Maternal characteristics of children
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surveyed did not differ from those of children lost to follow-up
(see Table S1 in Appendix S2). Maternal iron biomarkers did not
differ by trial arm and prevalence of maternal iron deficiency based
on low BIS at ANC2 was 16%. Prevalence of placental malaria
(active and past infection) was 86% in supplemented women and
81% in controls. Babies born to iron supplemented women had
shorter median gestational age and lower mean birthweight
(Brabin, Gies, et al., 2019). The median age of children surveyed
was 9.1 months (range 1–22 months), 20% were undernourished
(Z score ≤ 2SD), 2.2% were referred for severe malnutrition
(Z score ≤ 3SD) and three children had received recent
haematinics. Malaria and iron biomarker outcomes are outlined in
Table 2. In children ≥ 6 months, 69% were iron deficient (based on
a sTfR/log ferritin ratio > 5.6), 33% had low BIS and 98% were
anaemic. In children ≥ 6 months, low BIS prevalence was higher
than in younger children < 6 months (33% vs. 6%, P < 0.001).
Mean Hb concentration, iron biomarkers levels or anaemia preva-
lence in children did not differ between trial arms, nor were there
significant differences for any malaria-related outcomes. Median
CRP concentration increased from 2.7 mg L−1 in children ≤ 6 months
to 6.3 mg L−1 for older children (P < 0.001), but values did not dif-
fer by trial arm.
3.3 | Child malaria prevalence and iron biomarkers
for combined trial arms
Parasite prevalence increased from low values at 1 month to approxi-
mately 45% by 4 months, with positive RDT prevalence increasing to
70% at this age. Clinical malaria prevalence increased to 20% by
TABLE 1 Child and maternal characteristics by trial arm
Characteristic Iron Control
Child
Median age, months (IQR) 9.6 (4.6–14.4) 8.4 (3.2–13.6)
Age 6 months, n/N (%) 29/96 (30) 34/84 (40)
Male, n/N (%) 48/96 (50) 37/84 (44)
Median weight, kg (IQR) 6.9 (5.7–8.4) 7.3 (5.7–8.2)
Undernutrition (Z score < 2), n/N (%) 23/96 (24) 13/84 (15)
Median birthweight, g (IQR) 2756 (2459–3022) 2896 (2518–3065) (4 missing)
Median gestational age, days (IQR) 269 (260–275) (8 missing) 273 (265–280) (4 missing)
Preterm < 37 weeks, n/N (%) 21/88 (24) 8/80 (10)
SGA, n/N (%) 23/88 (26) 23/80 (29)
Maternal parameters at ANC1
Median BMI, kg m−1 (IQR) 21.3 (19.9–22.6) (9 missing) 20.8 (20.2–21.6) (3 missing)
Median Hb, g dl−1, N (IQR) 10.1 (9.3–11.0) (8 missing) 10.2 (9.1–11.1) (2 missing)
Median sTfR/log ferritin ratioa (IQR) 3.2 (2.5–4.2) (8 missing) 3.0 (2.4–4.4) (4 missing)
Median body iron stores, mg kg−1 (IQR) 6.5 (4.5–9.1) (9 missing) 6.9 (4.0–9.7) (4 missing)
Median hepcidin, nmol L−1 (IQR) 2.2 (0.8–5.3) (9 missing) 2.8 (0.7–7.0) (2 missing)
Median CRP, mg L−1 (IQR) 5.6 (2.01–12.2) (9 missing) 4.1 (0.9–12.2) (2 missing)
Malaria parasite positive, n/N (%) 46/87 (53) 45/82 (55)
Maternal parameters at ANC 2
Median sTfR/log ferritin ratioa (IQR) 4.1 (3.0–6.3) (20 missing) 4.6 (3.0–6.8) (11 missing)
Median body iron stores, mg kg−1 (IQR) 4.7 (1.0–7.9) (21 missing) 4.0 (0.8–6.5) (13 missing)
Median hepcidin, nmol L−1 (IQR) 0.9 (0.4–3.0) (21 missing) 0.7 (0.3–2.5) (11 missing)
Median CRP, mg L−1 (IQR) 4.08 (1.19–12.11) (21 missing) 2.11 (1.14–4.88) (12 missing)
IPTp received (≥2), n/N (%) 69/96 (72) 66/82 (80)
Maternal parameters at delivery
Placental malaria: None, n/N (%) 8/58 (14) 11/59 (19)
Placental malaria: Active, n/N (%) 18/58 (31) 11/59 (19)
Placental malaria: Past, n/N (%) 32/58 (55) 37/59 (63)
Chorioamnionitis, n/N (%) 25/58 (43) 30/56 (54)
Abbreviations: BMI, body mass index; CRP, C-reactive protein; Hb, haemoglobin; IQR, interquartile range; IPTp, intermittent preventive antimalarial
treatment with sulphadoxine pyrimethamine in pregnancy; SGA, small for gestational age; sTfR, serum transferrin receptor. Control group includes one pair
of twins with birthweights < 2500 g.
aLog (sTfR/log ferritin ratio) uses value for adjusted ferritin.
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7 months. Prevalence of all malaria infection parameters progressively
increased with age (Figure 1).
The age-specific pattern of child iron biomarkers is shown in
Figure 2 in relation to malaria parasitaemia. Malaria infection was
associated at all ages with lower Hb, higher CRP concentration and
higher values for adjusted ferritin (P < 0.001) and BIS (P < 0.001). Sim-
ilar iron biomarker differences were seen in relation to parasitaemia
and/or recent malaria treatment (see Figure S2). Parasitaemia risk was
higher with evidence of childhood iron repletion (Table 3). The risk
estimate (OR) for malaria parasitaemia with BIS (per mg kg−1 increase)
was 1.13 (95% CI 1.04–1.23, P = 0.002) and for parasitaemia and/or
recent malaria treatment 1.18 (95% CI 1.09–1.29, P < 0.001). Higher
zinc protoporphyrin concentration was associated with malaria infec-
tion (P = 0.003). Gestational age at delivery, SGA, and child undernu-
trition were not associated with childhood malaria risk.
Child malaria infection prevalence grouped by categories of active
and past placental infection are shown in Figure 3. Placental malaria
infection was associated with higher malaria infection prevalence at
all child ages. The difference in childhood malaria infection risk associ-
ated with placental malaria occurred after about 3–4 months of age
and persisted through the second year. The difference in childhood
malaria infection prevalence associated with active or past placental
infection was ≤10%, with higher estimates for active placental infec-
tion. Effect estimates for this risk associated with placental malaria
TABLE 2 Child outcomes by trial arm
Outcome Iron Control Differencea (95% CI) P value
Malaria related
RDT positive, n/N (%) 69/95 (73) (1 missing) 60/84 (71) 0.8 (0.3–1.9) 0.60
Microscopy positive, n/N (%) 36/95 (38) (1 missing) 26/84 (31) 1.4 (0.7–2.7) 0.31
Clinical malaria, n/N (%) 14/96 (15) 9/84 (11) 1.3 (0.5–3.3) 0.62
Parasite density per mm3 (N) (IQR) 6201 (36) (823–15780) 3900 (851–17496) (26) 0.72 (0.25–2.06) 0.53
Fever (≥37.5C), n/N (%) 13/96 (14) 7/84 (8) 1.5 (0.5–4.2) 0.44
Fever in last 14 days, n/N (%) 26/96 (27) 24/84 (29) 0.8 (0.4–1.5) 0.44
Malaria treatment last 14 days, n/N (%) 17/96 (18) 17/84 (20) 0.8 (0.3–1.7) 0.48
Number of malaria episodes since
birth, N (IQR)
1 (0–2) (2 missing) 1 (0–2) −0.1 (−0.4 to 0.2) 0.51
Any illness in last 14 days, n/N (%) 49/96 (51) 43/84 (51) 0.8 (0.4–1.6) 0.60
Anaemia and iron biomarkers
Median Hb, g dl−1 (N) (IQR) 8.7 (95) (7.4–9.7) (1 missing) 9.2 (7.6–10.0) (1 missing) −0.1 (−0.6 to 0.3) 0.53
Hb < 11 g dl−1 in children ≥ 6 months
age, n/N (%)
64/66 (97) (1 missing) 49/49 (100) (1 missing) NA NA
Median CRP, mg L−1 (N) (IQR) 6.2 (2.1–19.0) (2 missing) 4.6 (1.1–13.4) (1 missing) 1.4 (0.8–2.3) 0.23
Median adjusted ferritin, μg L−1 (IQR)b 64.8 (20.6–199.3) (11 missing) 57.4 (19.7–211.8) (9 missing) 1.2 (0.8–1.8) 0.31
Median sTfR, μg ml−1 (IQR) 17.5 (9.8–24.6) (3 missing) 14.4 (9.5–20.3) (2 missing) 1.1 (0.9–1.3) 0.41
sTfR/log ferritin ratio (IQR)c 9.0 (4.5–14.6) (12 missing) 8.0 (5.2–11.2) (10 missing) 1.0 (0.8–1.2) 0.78
Median ZPP, μmol mol−1 haem (IQR) 196 (146–319) (1 missing) 206 (143–257) (1 missing) 1.0 (0.9–1.2) 0.47
Median body iron stores, mg kg−1 (IQR) 3.7 (0.1–8.5) (12 missing) 3.8 (0.2–8.1) (10 missing) 0.6 (−0.8 to 2.1) 0.40
Note: NA, insufficient data to compute OR.
Abbreviations: CRP, C-reactive protein; Hb, haemoglobin; IQR, interquartile range; sTfR, serum transferrin receptor; RDT, rapid diagnostic test; ZPP, whole
blood zinc erythrocyte protoporphyrin.
aDifference for continuous variables, odds ratio for dichotomous variables. Where variables are log transformed, the difference in logged values can be
interpreted as a ratio.
bFerritin adjusted with internal regression correction using common slope.
cLog (sTfR/log ferritin ratio) uses adjusted ferritin.
F IGURE 1 Malaria prevalence by age in children under 2 years.
Shaded areas are ±1SE around the fitted line. RDT, rapid malaria
diagnostic test; ACT, recent antimalarial combination treatment.
Clinical malaria was defined as fever or history of fever (≥37.5C) in
previous 48 h with parasitaemia
6 of 13 GIES ET AL.
are shown in Table 3 which summarises child and maternal parame-
ters associated with current parasitaemia in children. An odds ratio for
child parasitaemia of 5.8 (95% CI, 1.0–32.5, P = 0.042) was associated
with active placental infection but was higher for parasitaemia and/or
recent malaria treatment (OR 10.0, 95% CI, 1.8–56.2, P = 0.008). Past
placental malaria infection also predicted child parasitaemia and/or
recent malaria treatment (OR 10.3, 95% CI 2.2–48, P = 0.003). Malaria
parasitaemia at ANC1 marginally increased the risk of childhood
parasitaemia (OR 2.0, 95% CI 1.0–4.3, P = 0.063). In children,
parasitaemia risk was higher with evidence of maternal inflammation
based on raised CRP (OR 2.1, 95% CI 1.1–3.9, P = 0.020) in the third
trimester. Chorioamnionitis at delivery was associated with reduced
risk of child parasitaemia (P = 0.038), although for child parasitaemia
or recent malaria treatment this reduction was not significant.
4 | DISCUSSION
Periconceptional iron supplementation made no difference to pla-
cental malaria parasite prevalence, or in children, to malaria-related
outcomes or iron biomarker values. When combining trial arms,
increased malaria infection prevalence was seen in children with
better iron status. There was increased childhood malaria infection
risk following active and past placental malaria, indicating that ear-
lier gestational malaria was also a risk factor for malaria in young
children, although the active infection had cleared by the time of
delivery.
The absence of a difference in child malaria outcomes or iron sta-
tus by trial arm is consistent with the findings that periconceptional
iron supplementation did not improve maternal iron status. There was
good adherence to weekly supplementation (79% iron; 80% control;
Gies et al., 2018), and the lack of effect of maternal iron supplementa-
tion was attributed to poor maternal iron absorption due to the high
prevalence (>40%) of chronic untreated asymptomatic malaria para-
sitaemias (Brabin, Tinto, & Roberts, 2019). In principle screening for
iron deficiency, prevalence would be implemented before introduction
of routine supplementation programmes. WHO in 2020 suggested
that a prevalence of 5–19.9% iron deficiency, based on ferritin con-
centrations, might be considered a mild public health problem (World
Health Organisation, 2020). Based on adjusted ferritin alone
(<15 μg L−1), prevalence at ANC1 in our study was 12.8% (Diallo
et al., 2020). Using BIS as an indicator, 16% of mothers in the last
F IGURE 2 Age-specific child iron biomarkers and malaria parasitaemia. (a) Adjusted ferritin; (b) ZPP, whole blood zinc protoporphyrin;
(c) sTfR, serum transferrin receptor; (d) BIS, body iron stores (horizontals line is zero body iron stores); (e) CRP, C-reactive protein and (f) Hb,
haemoglobin. Red line: malaria parasitaemia present; green line: malaria parasitaemia absent
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trimester and subsequently 6% of their infants aged ≤6 months had
values < 0 mg kg−1. Their relative iron repletion could predispose to
earlier onset malaria infection in infants. Routine iron supplementation
to young menstruating nulliparous women should not be rec-
ommended without prior effective malaria control as the majority
could be iron replete (Brabin et al., 2020). In programmatic terms
TABLE 3 Predictors of child malaria in combined trial arms
Predictor N
Current parasitaemia Current parasitaemia or recent malaria treatment
Odds ratio (95% CI) P value Differencea (95% CI) P value
Birth and nutrition
Sex: Male 85/179 0.7 (0.3–1.3) 0.22 1.1 (0.6–2) 0.86
Birthweight (per kg) 175 0.5 (0.2–1.2) 0.13 0.6 (0.2–1.4) 0.20
Gestation (per week) 168 1.0 (0.8–1.3) 0.81 1.1 (0.9–1.3) 0.41
Preterm < 37 weeks 29/168 1.2 (0.5–3.2) 0.67 0.9 (0.4–2.3) 0.87
Child undernutrition (Z score < 2) 36/179 1.3 (0.6–2.8) 0.56 1.5 (0.7–3.5) 0.29
Child anaemia and iron biomarkers
Hb 178 0.5 (0.4–0.7) <0.001 0.5 (0.4–0.7) <0.001
Adjusted ferritinb 160 4.0 (1.9–8.4) <0.001 5.6 (2.6–12.2) <0.001
Log (sTfR) 175 2.2 (0.5–10.5) 0.30 2 (0.4–9.2) 0.36
Log (sTfR/log ferritin ratio)c 158 0.4 (0.1–1.6) 0.19 0.2 (0–0.7) 0.015
Log (ZPP) 178 14.1 (2.3–85.7) 0.003 20.5 (3.3–129.2) <0.001
Body iron stores 158 1.13 (1.04–1.23) 0.002 1.18 (1.09–1.29) <0.001
Log (CRP) 177 2.9 (1.7–5.1) <0.001 3 (1.7–5.1) <0.001
Maternal parameters at ANC1
BMI 168 1.2 (0.9–1.4) 0.15 1 (0.8–1.3) 0.75
Hb 170 1.0 (0.8–1.3) 0.98 1.1 (0.8–1.4) 0.50
Log (sTfR/log ferritin ratio)c 167 1.0 (0.2–5.1) 0.97 1.3 (0.2–6.4) 0.78
Body iron stores 167 1.01 (0.93–1.11) 0.79 0.99 (0.91–1.08) 0.81
Log (hepcidin) 169 0.9 (0.5–1.6) 0.65 1.1 (0.6–2.1) 0.65
Log (CRP) 169 1.6 (0.9–2.8) 0.096 1.2 (0.7–2.1) 0.41
Malaria parasite positive 91/169 2.0 (1.0–4.3) 0.063 1.4 (0.7–2.8) 0.36
Maternal parameters at ANC2
Log (sTfR/log ferritin ratio)c 146 1.1 (0.2–6.6) 0.94 0.7 (0.1–4) 0.69
Body iron stores 146 1.02 (0.93–1.12) 0.70 1.04 (0.95–1.14) 0.39
Log (hepcidin) 148 1.2 (0.6–2.4) 0.64 1.2 (0.6–2.4) 0.56
Log (CRP) 147 2.1 (1.1–3.9) 0.020 1.7 (0.9–3) 0.070
IPTp received (≥2) 135/177 1.4 (0.7–3.2) 0.35 1.1 (0.5–2.3) 0.80
Placental pathology
Placental malaria: Noninfected 19 Reference Reference
Placental malaria: Active infectiond 29 5.8 (1.0–32.5) 0.042 10 (1.8–56.2) 0.008
Placental malaria: Past infectione 69 3.2 (0.7–14.1) 0.13 10.3 (2.2–48) 0.003
Chorioamnionitis 55/114 0.4 (0.1–1.0) 0.038 0.7 (0.3–1.7) 0.44
Abbreviations: ANC1/ANC2, scheduled first and second study antenatal visits; BMI, body mass index; CRP, C-reactive protein; Hb, haemoglobin; IPTp:
intermittent preventive antimalarial treatment in pregnancy with sulphadoxine pyrimethamine; SGA, small for gestational age; sTfR, serum transferrin
receptor; ZPP, whole blood zinc protoporphyrin.
aDifference for continuous variables, odds ratio for dichotomous variables. Where variables are log transformed, the difference in log values can be
interpreted as a ratio.
bFerritin adjusted with internal regression correction using common slope.
cLog (sTfR/log ferritin ratio) uses value for adjusted ferritin.
dActive infection: includes acute infection (only parasites and minimal haemozoin deposition in the macrophages but not fibrin) and chronic infection
includes parasites and haemozoin deposition.
ePast infection: haemozoin usually mixed with fibrin but no parasites.
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providing periconceptional iron routinely to these women, most of
whom were not iron deficient, also increased risk of preterm birth and
on this basis should not be recommended (Table 1; Brabin, Gies,
et al., 2019).
Younger babies would be more likely to have recrudescences
from congenital malaria which, in this area, affected 10% of new-
borns (Natama et al., 2017). Malaria parasite prevalence (with or
without prior treatment) and RDT positivity in children were, with
the exception of ZPP, strongly associated with biomarkers of better
iron status and iron repletion at all ages (Table 3). ZPP concentra-
tion was higher in children with malaria, but its specificity in chil-
dren, as well as in pregnant women, is reduced secondary to the
anaemia of inflammation (Asobayire, Adou, Davidson, Cook, &
Hurrell, 2001; Senga, Koshy, & Brabin, 2012; Stoltzfus et al., 2000).
Preterm delivery and low birthweight lead to higher iron require-
ments for growth and are factors likely to contribute to the high
prevalence of iron deficiency and anaemia in children older than
6 months in this area (Brabin, Gies, et al., 2019; Domellöf, 2017).
Malaria contributes an added risk for anaemia and infection had
been experienced by approximately 80% of children reaching
6 months of age. Comparable high iron deficiency and anaemia
prevalence has been reported in the Eastern region of Burkina Faso
in children 6–12 months of age (Bliznashka, Arsenault, Becquey,
Ruel, & Olney, 2020).
An early peak in malaria prevalence occurred at around 4 months
of age followed by uniformly rising prevalence with increasing age. An
early peak in prevalence was similarly associated with placental infec-
tion in a cohort of Cameroonian children (Le Hesran et al., 1997).
However in a cross-sectional survey an early peak may be an artefact
since age reflects intensity and cumulative exposure to malaria. Chil-
dren at 4 months may have had more exposure (almost a full season
at the time of the survey), compared with younger children who have
had less exposure, and older ones who have developed some acquired
immunity from a previous season's exposure (Natama, Rovira-Val-
lbona, Somé, et al., 2018). This would occur in children of mothers
with and without placental malaria, so does not explain the higher
malaria prevalence in those with placental malaria. A recent meta-
analysis of 11 studies found an overall malaria risk in young children
(adjusted hazard ratio 1.46, 95% CI 1.07–2.0, P < 0.001) associated
with malaria in pregnancy but via indeterminate mechanisms (Park
et al., 2020). Placental malaria may influence primarily risk for the first
infant malaria episode (Bouaziz et al., 2018; Le Hesran et al., 1997; Le
Port et al., 2011), and better child iron status could increase subse-
quent malaria risk (Georgiadou et al., 2019) and possibly risk of
nonmalarial infections (Natama, Rovira-Vallbona, Sorgho, et al., 2018;
Rachas et al., 2012).
Malaria risk in young children is also influenced by other mater-
nal factors, although this study found no association with gesta-
tional age, use of IPTp, SGA or child undernutrition. Evidence for an
association between IPT in pregnancy and malaria in infants is lim-
ited (Kakuru, Staedke, Dorsey, Rogerson, & Chandramohan, 2019).
Higher malaria risk has been reported in a single study of SGA
infants, but gestational age was not assessed by ultrasound and the
difference was marginal (Agbota, Polman, et al., 2019). Maternal–
fetal immunological interactions are important (Feeney, 2020;
Jagannathan, 2018). Innate immune modulation by placental malaria
F IGURE 3 Child malaria infection prevalence by placental malaria category. Red line: active placental malaria present; blue line: past placental
malaria present; green line: no placental malaria present. (a) Rapid diagnostic test positive, (b) malaria parasitaemia positive and (c) malaria
parasitaemia positive and/or recent treatment for malaria. Active indicates acute infection (only parasites and minimal haemozoin deposition in
the macrophages but not fibrin) and chronic infection (parasites and haemozoin deposition). Past indicates previous infection (haemozoin usually
mixed with fibrin but no parasites). Rugs along the axes indicate the positive (upper axis) and negative (lower axis) case
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is described in infants from this study area in Burkina Faso (Natama,
Moncunill, et al., 2018). Immunological interactions are especially
relevant in primigravidae who are at increased risk of malaria in high
transmission areas. In the present study, all women were
primigravidae and more than 90% were adolescent (Brabin
et al., 2020). The lower risk of child malaria observed in this study
with chorioamnionitis may be attributable to treatment of related
maternal symptoms of vaginal discharge from genital infection with
metronidazole, which has antimalarial effects and hence could
reduce placental parasite load (Pallangyo, Minjas, & Sarda, 1986).
Metronidazole for lower genital infections with vaginal discharge
was available free of charge both before and during pregnancy and
8.2% reported a discharge at least once during pregnancy (Brabin
et al., 2017; background data, Appendix S1).
Lack of adjustment for malaria transmission intensity is an
important limitation of the present study, as for nearly all published
studies, which may be confounded by shared maternal and child
exposures to infected mosquitoes (Kakuru, Staedke, Dorsey,
Rogerson, & Chandramohan, 2019). Adolescent malaria has been
associated with high gametocyte prevalence in Burkina Faso, which
would influence the reproductive rate and infection transmission
(Ouédraogo et al., 2010). Malaria infection risk could relate to an
effect of ferritin supply on gametocyte fecundity and parasite
ontogeny in the mosquito (Geiser, Conley, Elliott, Mayo, &
Winzerling, 2015). If mosquitos have higher malaria gametocyte
rates (enhanced by better iron substrates in their blood meal), then
the reproduction rate of malaria transmission increases. This would
impact on the local mosquito population and increase malaria
infant exposures. For this reason, infants of a largely iron replete
adolescent population could be at increased malaria infection
risk. Younger women may also provide different child care prac-
tices than older mothers which may impact their child's malaria
exposure and treatment. Iron requirements for adolescent
growth and for pregnancy and neonatal iron are competing factors
(Young et al., 2010), which underlines the need for longitudinal
studies of infection risk characterising iron biomarkers from
preconception.
No previous studies have longitudinally assessed both maternal
and child iron status as determining factors for childhood infection
risk in areas of high malaria transmission. Lack of efficacy of the pri-
mary intervention in mothers precluded better understanding of the
effects of supplementation on the iron status of their offspring.
Strengths of the present study include assessment of gestational
age by ultrasound, lack of confounding due to maternal parity or
age, inclusion of key determinants of maternal and child malaria and
completion of this cross-sectional survey during the peak month of
malaria transmission (Natama et al., 2018). The findings should be
generalizable to comparable areas with high malaria transmission. A
limitation was the reduced sample size for the child survey. This
was predicated by the primary safety trial endpoints in mothers and
the requirement to complete the survey during the peak malaria
transmission month. The sample size for the child safety survey was
reduced due to perinatal losses (Gies et al., 2018), as well as
migration outside the study area which contributed to failure to
attend for delivery, or led to postnatal migration and failure to
attend for the child survey. Mobility was high among girls as they
married and moved to join their husbands in nonstudy areas
(Campaoré, Gies, Brabin, Tinto, & Brabin, 2018). Village deliveries
and those occurring en route to the hospital reduced placental
biopsy samples. Attrition and child nutritional and age profiles were
equivalent between trial arms.
5 | CONCLUSIONS
High prevalence of placental and child malaria was associated with
better iron status in young mothers and children. Intensified efforts
are needed to reduce risk of placental malaria which should, in turn,
reduce risk of malaria and anaemia in young children.
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